Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet - TMS ShortLINK
News Update
Loading...
Without Label Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet

Monday, March 8, 2021

Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet

      Comment   
----YOU ADS---
----YOU ADS---
Covaxin, the homegrown coronavirus vaccine that was authorized for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has... ----YOU ADS---
----YOU ADS---

Share with your friends

Give us your opinion

How To Use
  • Put the link on the
  • Generate Link box with http:// or https://
  • Use  CTRL + V  on keyboard to put the link.
  • Click Generate button to get encrypted link.
  • Click Copy URL button.
    • Done